Management of Type 2 Diabetes in Stage C Heart Failure with Reduced Ejection Fraction
Type 2 diabetes is an increasingly common comorbidity of stage C heart failure with reduced ejection fraction (HFrEF). The two diseases are risk factors for each other and can bidirectionally independently worsen outcomes. The regulatory requirement of cardiovascular outcomes trials for antidiabetic...
Main Authors: | Anjali Agarwalla, Jadry Gruen, Carli Peters, Lauren Sinnenberg, Anjali T Owens, Nosheen Reza |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2022-03-01
|
Series: | Cardiac Failure Review |
Online Access: | https://www.cfrjournal.com/articleindex/cfr.2021.31 |
Similar Items
-
Representation of women in heart failure clinical trials: Barriers to enrollment and strategies to close the gap
by: Nosheen Reza, et al.
Published: (2022-01-01) -
Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
by: Dan Liu, et al.
Published: (2023-04-01) -
Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
by: Tin‐Kwang Lin, et al.
Published: (2019-06-01) -
Editorial: Edema in heart failure with reduced ejection fraction
by: Inna P. Gladysheva, et al.
Published: (2023-02-01) -
Role of interleukins in heart failure with reduced ejection fraction
by: Oliwia Anna Segiet, et al.
Published: (2019-11-01)